Interpretation of the clinical practice guidelines for Ketamine in total joint arthroplasty in 2022 / 国际外科学杂志
International Journal of Surgery
; (12): 203-206, 2024.
Article
en Zh
| WPRIM
| ID: wpr-1018115
Biblioteca responsable:
WPRO
ABSTRACT
The American Association of Hip and Knee Surgeons, the American Academy of Orthopaedic Surgeons, and the American Society of Regional Anesthesia and Pain Medicine collaborated to develop an evidence-based study about the safe and effective use of Ketamine in total joint arthroplasty(TJA). Based on the systematic review and Meta-analysis of several studies, the following conclusions are drawn: Ketamine can effectively relieve the postoperative pain of patients; Ketamine can effectively reduce the occurrence of postoperative nausea and vomiting; Ketamine can reduce the use of postoperative opioids; intraoperative use of Ketamine does not increase the incidence of postoperative adverse reactions. The above conclusions are graded according to the strength of evidence support. This article interprets the guidelines to provide reference for addressing the effectiveness and safety of Ketamine use in TJA.
Texto completo:
1
Banco de datos:
WPRIM
Idioma:
Zh
Revista:
International Journal of Surgery
Año:
2024
Tipo del documento:
Article